Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendP =0.061.2× alpha
The subgroup that received a combination of bevacizumab with a regimen of chemotherapy showed a trend of improvement without significance (HR =0.91; 95% CI, 0.83–1.00; Z=1.91, P =0.06 for PC-based chemotherapy, HR =0.91; 95% CI, 0.77–1.07; Z=1.16, P =0.25 for non-PC-based chemotherapy).
showed a trendp = 0.061.2× alpha
In the multiple linear regression models with mean BP over the recording period and penumbra as the independent variables, the LF phase in the AH was significantly associated with penumbra ( p = 0.04) and showed a trend-level association with mean BP ( p = 0.06). 3.3.4.
showed a trendp =0.061.2× alpha
Patients with sEGFR levels above 55 μg/l had a significantly longer overall survival ( Figure 1a , log rank p =0.033), while patients with a log CEA level below 1.1 showed a trend toward longer overall survival ( Figure 1b , log rank p =0.06).
showed a trendp = 0.061.2× alpha
Compared with C/EBPα-wild-type patients, patients with C/EBPα mutations showed a trend for a better CR rate (93% vs. 77%; p = 0.06) and significantly higher 5-year rates of EFS (55% vs. 17%; p < 0.001), DFS (53% vs. 23%; p = 0.001) and OS (58% vs. 27%; p = 0.002) [ 80 ] (Table 3 ).
showed a trendP =0.061.2× alpha
High-level microsatellite instability CRCs showed a trend towards a higher infiltration with FOXP3-positive cells in the tumour stroma (median: 181.5 cells per 0.25 mm 2 in MSI-H vs 137.1 cells per 0.25 mm 2 in MSS, P =0.06) and a significantly higher intraepithelial infiltration with FOXP3-positive Treg cells (median: 8.5 cells per 0.25 mm 2 in MSI-H vs 3.1 cells per 0.25 mm 2 in MSS, P <0.001).
showed a trendP =0.061.2× alpha
In addition, patients with RRM1 mRNA expression in the lowest quartile attained a significantly higher time to progression ( P =0.044) and overall survival ( P =0.02) and showed a trend towards a higher response rate ( P =0.06), compared to patients in the highest quartile of RRM1 expression.